Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

NCT00776867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: perifosine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]